Management of restless legs syndrome augmentation (Q48388609)

11 February 2018

title

Management of restless legs syndrome augmentation (English)

1 reference

11 February 2018

main subject

restless legs syndrome

1 reference

Anne-Marie Williams

1 reference

11 February 2018

Diego Garcia-Borreguero

series ordinal

1 reference

11 February 2018

publication date

1 September 2009

1 reference

11 February 2018

Current treatment options in neurology

published in

1 reference

11 February 2018

volume

1 reference

11 February 2018

issue

1 reference

11 February 2018

page(s)

327-332

1 reference

11 February 2018

Long-term effect of dopaminergic drugs in restless legs. A 2-year follow-up

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11940-009-0036-2

A controlled study of additional sr-L-dopa in L-dopa-responsive restless legs syndrome with late-night symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-009-0036-2

Dopaminergic treatment of restless legs and rebound phenomenon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-009-0036-2

Long-term effects of pergolide in the treatment of restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-009-0036-2

Effective cabergoline treatment in idiopathic restless legs syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-009-0036-2

Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute

21 January 2018

1 reference

12 December 2020

A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome

1 reference

12 December 2020

A randomized, double-blind placebo-controlled trial of iron in restless legs syndrome.

1 reference

12 December 2020

Augmentation: understanding a key feature of RLS.

1 reference

12 December 2020

Validation of the Augmentation Severity Rating Scale (ASRS): a multicentric, prospective study with levodopa on restless legs syndrome

1 reference

12 December 2020

Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: results from a multi-center, randomized, active controlled trial.

1 reference

12 December 2020

Restless legs syndrome prevalence and impact: REST general population study

1 reference

12 December 2020

Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS).

1 reference

12 December 2020

Augmentation of the restless legs syndrome with carbidopa/levodopa.

1 reference

12 December 2020

Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial

1 reference

12 December 2020

Treatment of restless legs syndrome: an evidence-based review and implications for clinical practice

1 reference

12 December 2020

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

1 reference

12 December 2020

Role of dopamine receptor agonists in the treatment of restless legs syndrome

1 reference

12 December 2020

Augmentation in restless legs syndrome is associated with low ferritin

1 reference

12 December 2020

Restless legs syndrome augmentation and pramipexole treatment

1 reference

12 December 2020

Pergolide and carbidopa/levodopa treatment of the restless legs syndrome and periodic leg movements in sleep in a consecutive series of patients.

1 reference

12 December 2020

Dopamine and iron in the pathophysiology of restless legs syndrome (RLS).

1 reference

12 December 2020

A clinical and polysomnographic comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome

1 reference

12 December 2020

Restless legs syndrome augmentation associated with tramadol

1 reference

12 December 2020

A polysomnographic study on periodic limb movements in patients with restless legs syndrome and neuroleptic-induced akathisia

1 reference

12 December 2020

Pramipexole in the management of restless legs syndrome: an extended study

1 reference

12 December 2020

Augmentation of restless legs syndrome with long-term tramadol treatment

1 reference

12 December 2020

Pergolide in the Management of Restless Legs Syndrome: An Extended Study

1 reference

12 December 2020

Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome

1 reference

12 December 2020

Polysomnographic Characteristics of Neuroleptic-Induced Akathisia

1 reference

12 December 2020

Augmentation as a treatment complication of restless legs syndrome: concept and management

1 reference

12 December 2020

10.1007/S11940-009-0036-2

Identifiers

DOI

1 reference

11 February 2018

release_h7czlrur3vdyhihxqsogs4dr2m

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h7czlrur3vdyhihxqsogs4dr2m

24 November 2022

mapped directly with Wikidata item

1 reference

11 February 2018